Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Hexahydroazepine
2. Hexahydroazepine Hydrochloride
3. Perhydroazepine
1. Azepane
2. 111-49-9
3. Hexahydroazepine
4. Perhydroazepine
5. Homopiperidine
6. Hexamethylenimine
7. Hexahydro-1h-azepine
8. 1h-azepine, Hexahydro-
9. Azacycloheptane
10. 1-azacycloheptane
11. Azepan
12. Cyclohexamethylenimine
13. Hexamethylene Imine
14. Azepine, Hexahydro-
15. Nsc 16236
16. Mfcd00006934
17. Czd076g73r
18. G 0
19. Chebi:32616
20. Nsc-16236
21. Dsstox_cid_6879
22. Dsstox_rid_78234
23. Dsstox_gsid_26879
24. Cycloheptane, 1-aza-
25. Cas-111-49-9
26. Hsdb 562
27. Einecs 203-875-9
28. Un2493
29. Brn 0001084
30. Unii-czd076g73r
31. Cp 18407
32. Ai3-26610
33. Ccris 8886
34. Azepane #
35. Hexamethyleneimine, 99%
36. Wln: T7mtj
37. Hexamethylene Imine (hmi)
38. Ec 203-875-9
39. 5-20-04-00003 (beilstein Handbook Reference)
40. Chembl1375444
41. Dtxsid1026879
42. Hexamethyleneimine [hsdb]
43. 2,3,4,5,6,7-hexahydroazepine
44. Act03374
45. Cs-b0958
46. Nsc16236
47. Str01425
48. Zinc3636476
49. Tox21_201482
50. Tox21_303304
51. Stl124104
52. Akos000119078
53. Un 2493
54. 2,3,4,5,6,7-hexahydro-1h-azepine
55. Ncgc00091040-01
56. Ncgc00091040-02
57. Ncgc00257117-01
58. Ncgc00259033-01
59. Bp-30036
60. H0092
61. D77224
62. Hexamethyleneimine [un2493] [flammable Liquid]
63. Q421530
64. J-002592
65. J-521455
66. Z57127566
67. F2190-0324
| Molecular Weight | 99.17 g/mol |
|---|---|
| Molecular Formula | C6H13N |
| XLogP3 | 1.2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 0 |
| Exact Mass | 99.104799419 g/mol |
| Monoisotopic Mass | 99.104799419 g/mol |
| Topological Polar Surface Area | 12 Ų |
| Heavy Atom Count | 7 |
| Formal Charge | 0 |
| Complexity | 37.4 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
HEXAMETHYLENEIMINE WAS FOUND TO BE A URINARY METABOLITE OF THE CARCINOGEN N-NITROSOHEXAMETHYLENEIMINE IN MALE RATS.
GRANDJEAN CJ; METABOLISM OF N-NITROSOHEXAMETHYLENEIMINE; J NATL CANCER INST 57(1) 181 (1976)
HEXAMETHYLENIMINE WAS FOUND TO BE A URINARY METABOLITE OF PIVMECILLINAM IN HUMANS.
HATTORI M ET AL; METABOLITES OF PIVMECILLINAM IN HUMAN URINE; CHEMOTHERAPY (TOKYO) 25(1) 123 (1977)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
ABOUT THIS PAGE
A Hexahydroazepine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Hexahydroazepine, including repackagers and relabelers. The FDA regulates Hexahydroazepine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Hexahydroazepine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Hexahydroazepine supplier is an individual or a company that provides Hexahydroazepine active pharmaceutical ingredient (API) or Hexahydroazepine finished formulations upon request. The Hexahydroazepine suppliers may include Hexahydroazepine API manufacturers, exporters, distributors and traders.
click here to find a list of Hexahydroazepine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Hexahydroazepine DMF (Drug Master File) is a document detailing the whole manufacturing process of Hexahydroazepine active pharmaceutical ingredient (API) in detail. Different forms of Hexahydroazepine DMFs exist exist since differing nations have different regulations, such as Hexahydroazepine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Hexahydroazepine DMF submitted to regulatory agencies in the US is known as a USDMF. Hexahydroazepine USDMF includes data on Hexahydroazepine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Hexahydroazepine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Hexahydroazepine suppliers with USDMF on PharmaCompass.
Hexahydroazepine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Hexahydroazepine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Hexahydroazepine GMP manufacturer or Hexahydroazepine GMP API supplier for your needs.
A Hexahydroazepine CoA (Certificate of Analysis) is a formal document that attests to Hexahydroazepine's compliance with Hexahydroazepine specifications and serves as a tool for batch-level quality control.
Hexahydroazepine CoA mostly includes findings from lab analyses of a specific batch. For each Hexahydroazepine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Hexahydroazepine may be tested according to a variety of international standards, such as European Pharmacopoeia (Hexahydroazepine EP), Hexahydroazepine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Hexahydroazepine USP).
LOOKING FOR A SUPPLIER?
